Key Takeaways
- AOD-9604 is not FDA-approved and is available for research purposes only, affecting its cost and availability.
- Typical costs for AOD-9604 can vary widely based on brand and compounding options, with many patients paying out of pocket.
- Insurance coverage for AOD-9604 is rare, as it is not FDA-approved for therapeutic use.
- HSA/FSA funds may not cover AOD-9604 due to its research-only status.
- Cost-saving options include exploring compounding pharmacies (where legal) and discount programs.
What Is AOD-9604?
AOD-9604 is a growth hormone fragment peptide consisting of amino acids 177–191 of the human growth hormone sequence. It is primarily used in metabolic research and adipocyte differentiation studies. AOD-9604 operates by modulating lipid and glucose metabolism pathways through β-adrenergic and AMPK-related mechanisms. For more detailed information, visit the AOD-9604 full profile.
Typical Cost Ranges
AOD-9604 is not FDA-approved for therapeutic use and is available for research purposes only. As such, it is not legally available for therapeutic use in the United States, which significantly impacts cost information and availability. When available through research channels, costs can vary:
- Brand-name medication: Typically unavailable due to its research-only status.
- Compounded version: Prices can range from $50 to $150 per vial, depending on the compounding pharmacy and volume purchased.
- Per-dose vs. monthly cost: Patients involved in research may see costs ranging from $100 to $300 monthly, depending on dosing frequency and concentration.
Due to its restricted status, most individuals involved in research pay out of pocket.
Insurance Coverage
Insurance coverage for AOD-9604 is virtually nonexistent due to its classification as a research-only substance. FDA-approved peptides are more likely to receive coverage, but AOD-9604 does not fall into this category. Patients involved in research should be prepared to cover costs independently, as compounded peptides are rarely covered.
HSA/FSA Eligibility
AOD-9604 does not typically qualify for HSA/FSA spending due to its status as a research peptide. These accounts usually cover FDA-approved treatments or those deemed medically necessary, which does not apply to AOD-9604.
Telehealth vs. In-Person Pricing
Telehealth clinics often bundle consultation and medication into monthly programs, which can offer convenience and potential cost savings for research participants. However, given the research-only status of AOD-9604, availability through telehealth services may be limited. In-person research settings may offer more consistent access.
